Genetec announces favorable conclusion in patent infringement case; Breaks silence on patent trolls
Company takes occasion of litigant’s settlement payment to make public its firm stance against nuisance lawsuits from non-practicing entities
Montreal, August 11, 2020 - “We don’t negotiate payment with patent trolls,” said Pierre Racz, President of Genetec Inc. (“Genetec”), a leading technology provider of unified security, public safety, operations, and business intelligence solutions, as the company announced that a patent infringement lawsuit initiated by a non-practicing entity (NPE) was withdrawn by the NPE at an early stage of the proceedings. In a rare result, the NPE paid an undisclosed sum to Genetec. In patent litigation in the United States, it is highly unusual for a plaintiff to pay a defendant to resolve a case.
Genetec understands that legal attacks from non-practicing entities are an unfortunate part of the technology business, representing a reported 90% of high-tech patent litigation cases in 2019 alone1. The practice, known as "patent trolling", involves groups that don't create technology, but rather aggregate patents that are generally of no technological value to use as the basis to initiate IP infringement cases against businesses.
Widely disparaged by courts, legal scholars, and world leaders including former U.S. President Barack Obama, as a form of legal extortion2, these pursuits are estimated to cost businesses tens of billions of dollars per year3. Although the number of patent trolling cases has flattened1 since a landmark 2014 US Supreme Court decision4, many groups continue to attempt to leverage hoarded patents as a legal bullying tactic against companies that actively innovate. While larger firms facing this sort of litigation are more often reported on, the majority of victims of patent trolling are smaller companies or startups (below $10M in revenue)5.
"Unlike the way many other companies deal with these sorts of attacks, we do not negotiate payment with patent trolls," said Pierre Racz, President of Genetec Inc. "Despite the potentially high cost of litigation, bending to their anti-innovation tactics only encourages their behavior and, as a matter of principle, Genetec will always vigorously defend its technology and the hard work of the people who create it. Though we have quietly followed this course since the first patent troll arrived at our door, we felt that this occasion was a good time to speak out against this practice."
"This represents an important symbolic victory for Genetec, and a clear demonstration of our policy of never paying nuisance value settlements," said Jean-Yves Pikulik, Director of Intellectual Property at Genetec. "While we would much rather spend our time patenting our innovations than fighting off patent trolls, we will continue to vigorously defend ourselves against NPEs and seek legal costs in lawsuits that we perceive as frivolous."
This resolution settles all outstanding claims by the non-practicing entity against Genetec.
https://hbr.org/2014/07/the-evidence-is-in-patent-trolls-do-hurt-innovation 4https://www.supremecourt.gov/opinions/13pdf/13-298_7lh8.pdf 5https://digitalcommons.law.scu.edu/cgi/viewcontent.cgi?referer=&httpsredir=1&article=1554&context=facpubs
Genetec Inc. is an innovative technology company with a broad solutions portfolio that encompasses security, intelligence, and operations. The company's flagship product, Security Center, is an open-architecture platform that unifies IP-based video surveillance, access control, automatic license plate recognition (ALPR), communications, and analytics. Genetec also develops cloud-based solutions and services designed to improve security, and contribute new levels of operational intelligence for governments, enterprises, transport, and the communities in which we live. Founded in 1997, and headquartered in Montréal, Canada, Genetec serves its global customers via an extensive network of resellers, integrators, certified channel partners, and consultants in over 80 countries.
For more information about Genetec, visit: genetec.com
-- 30 --